Loading organizations...
Key people at Huagai Capital.
Huagai Capital was founded in 2012 by Xiaolin Xu (Chairman & Co-founder) and Lu Binghui (President & Co-Founder).
Huagai Capital is a private equity investment firm based in Beijing, China, focused on investing in start-up and growth-stage companies across healthcare, technology, media, telecommunications (TMT), cultural sectors, business services, and transport. The firm manages nearly 20 billion RMB in assets under management (AUM) and has completed 139 past transactions. Huagai Capital has established industrial funds in healthcare, TMT, and digital innovation, closing three funds between April 2020 and January 2022. Its portfolio includes notable companies such as Kelun Pharmaceutical, BioKangtai, Joinn Biologics, Synaire, and Sangon Biotech. Key figures at the firm include Chairman and Co-Founder Xiaolin Xu, Managing Partners Zeng Zhiqiang and Eric Tsang, and Founding Partner Binghui Lu. Huagai Capital was co-founded in 2012 by professionals including Xiaolin Xu.
Key people at Huagai Capital.
Huagai Capital was founded in 2012 by Xiaolin Xu (Chairman & Co-founder) and Lu Binghui (President & Co-Founder).
Huagai Capital has 13 tracked investments across 11 companies. The latest tracked deal is $72.8M Series C in QL Biopharma in March 2026.
